Showing results (121-130 of 146) with videos related to
Sort By:
Pageof 15
British Journal of Cancer|April 3, 1999
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus scheduleA Awada, C J Punt, M J Piccart, et al.Cancer|November 1, 1983
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IVD J Wagener, J M Burgers, A W Dekker, et al.Anticancer Research|January 1, 1993
Results of treatment of the adenocarcinoma of the esophagusP J Janssens, D J Wagener, F M Nagengast, et al.Anti-Cancer Drugs|April 1, 1995
Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.Gut|August 1, 1990
Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activityR J van Klaveren, P H de Mulder, A M Boerbooms, et al.Investigational New Drugs|January 1, 1995
Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatinH P Hofs, D J Wagener, V De Valk-Bakker, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG studyD J Wagener, W J Hoogenraad, P Rougier, et al.Journal of the National Cancer Institute|April 1, 1987
In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesisZ Zylicz, D J Wagener, H van Rennes, et al.Surgical Endoscopy|November 1, 1997
Laparoscopic fundoplication to enhance pulmonary function in children with severe reactive airway disease and gastroesophageal reflux diseaseS S Rothenberg, D Bratton, G Larsen, et al.Cancer Letters|July 1, 1986
In vivo potentiation of cis-diamminedichloroplatinum (II) antitumor activity by pretreatment with sparsomycinZ Zylicz, D J Wagener, H van Rennes, et al.Pageof 15